Scientist Home Future Health (SHFH) EBITDA Margin (2025)

Scientist Home Future Health's (SHFH) quarterly EBITDA Margin came in at 174.41% in Q4 2025, down 38.07% quarter-over-quarter from 126.32% in Q3 2025.

Scientist Home Future Health (SHFH) EBITDA Margin (2025) Analysis & Trends

Scientist Home Future Health has disclosed EBITDA Margin across 1 years of filings, most recently posting 174.41% for Q4 2025.

  • EBITDA Margin for Q4 2025 came in at 174.41%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 114.96% (changed N/A YoY), and the FY2025 annual result was 114.96%, down 10256.0% from the prior year.
  • EBITDA Margin came in at 174.41% for Q4 2025 at Scientist Home Future Health, down from 126.32% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 13.49% in Q1 2025 to a low of 174.41% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 High Tide 558.20 Mn 531.28 Mn 32.00 Mn -0.39%
2 Wellgistics Health 385.01 Mn 384.95 Mn 170,221.00 -385.72%
3 Petmed Express 35.71 Mn 8.80 Mn 9.46 Mn -25.75%
4 Scienture Holdings 14.72 Mn 14.72 Mn 53,850.00 -6,230.80%
5 Ridgetech 15.50 -4.11 Mn - -
6 Scientist Home Future Health - - 32,589.00 -174.41%
7 BioScience Health Innovations - - 485,596.00 -30.62%
8 Rest Ez - - - -
9 Polomar Health Services - - 550,489.00 -0.69%

Historic Data

Download Data
DateValue
Dec 31, 2025 -174.41%
Sep 30, 2025 -126.32%
Jun 30, 2025 -117.25%
Mar 31, 2025 13.49%